Alpha Tau Medical Ltd.
DRTS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $8,307 | $7,012 | $7,170 | $7,533 |
| G&A Expenses | $1,933 | $2,177 | $1,679 | $2,054 |
| SG&A Expenses | $2,423 | $2,636 | $2,138 | $2,741 |
| Sales & Mktg Exp. | $490 | $459 | $459 | $687 |
| Other Operating Expenses | -$59,372 | $0 | $0 | $0 |
| Operating Expenses | -$48,642 | $9,648 | $9,308 | $10,274 |
| Operating Income | $48,642 | -$9,648 | -$9,308 | -$10,274 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$60,336 | -$401 | $716 | $800 |
| Pre-Tax Income | -$11,694 | -$10,049 | -$8,592 | -$9,474 |
| Tax Expense | $8 | $65 | $99 | $2 |
| Net Income | -$11,686 | -$10,114 | -$8,691 | -$9,476 |
| % Margin | – | – | – | – |
| EPS | -0.14 | -0.13 | -0.12 | -0.14 |
| % Growth | -7.7% | -8.3% | 14.3% | – |
| EPS Diluted | -0.14 | -0.13 | -0.12 | -0.14 |
| Weighted Avg Shares Out | 83,752 | 80,354 | 70,451 | 70,092 |
| Weighted Avg Shares Out Dil | 85,260 | 80,354 | 70,451 | 70,092 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $944 | $716 | $800 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $276 | $0 | $0 | $276 |
| EBITDA | -$10,455 | -$9,177 | -$9,308 | -$5,398 |
| % Margin | – | – | – | – |